Showing results (121-130 of 542) with videos related to

Sort By:
Pageof 55
The British Journal of Clinical Practice|September 1, 1989
A double-blind placebo-controlled crossover study of mebeverine and mefenamic acid in the treatment of primary dysmenorrhoeaA F Langrick, A D Gunn, H Livesey, et al.
Developmental Pharmacology and Therapeutics|January 1, 1987
Methotrexate polyglutamate synthesis in lymphoblasts from children with acute lymphoblastic leukemiaV M Whitehead, D S Rosenblatt, M J Vuchich, et al.
Global Advances in Integrative Medicine and Health|March 19, 2024
Remote Delivery of Mindful Movement Within Healthcare Systems: Lessons Learned From the Veterans Health AdministrationAlison M Whitehead, Rashmi Mullur, Marlysa B Sullivan, et al.
Journal of Vitreoretinal Diseases|January 15, 2024
Incidence of Total Blindness After Central Retinal Artery Occlusion With Ocular NeovascularizationHarshvardhan Chawla, Hayley J Redrick, Joshua T Pannell, et al.
Clinical Endocrinology|May 1, 1991
Physiological growth hormone secretion in adult growth hormone deficiency: comparison with normal controlsH M Whitehead, B Aiken, S Lewis, et al.
International Journal of Epidemiology|December 1, 1990
Malignant melanoma in England: risks associated with naevi, freckles, social class, hair colour, and sunburnJ M Elwood, S M Whitehead, J Davison, et al.
Journal of Music Therapy|July 25, 2007
Exploring the effects of music therapy on pediatric pain: phase 1Annette M Whitehead-Pleaux, Natasha Zebrowski, Mary Jo Baryza, et al.
The Gerontologist|June 14, 2011
Impact of participation in TimeSlips, a creative group-based storytelling program, on medical student attitudes toward persons with dementia: a qualitative studyDaniel R George, Heather L Stuckey, Caroline F Dillon, et al.
Vitamins and Hormones|March 23, 2021
Nuclear receptors linking physiology and germline stem cells in DrosophilaDanielle S Finger, Kaitlin M Whitehead, Daniel N Phipps, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2000
Second primary malignancies following the treatment of early stage ovarian cancer: update of a study by the National Cancer Institute of Canada--Clinical Trials Group (NCIC-CTG)S F Dent, D Klaassen, J L Pater, et al.
Pageof 55